Single-crystal structure and intracellular localization of Zn(II)-thiosemicarbazone complex targeting mitochondrial

Jinxu Qi1, Wei Zhao1, Yunyun Zheng1

  • 1Medcine College of Pingdingshan University, Pingdingshan, Henan 467000, China.

Insights

A novel zinc(II)-thiosemicarbazone complex, Zn(AP44eT)(NO3)2, effectively targets cancer cell mitochondria for imaging and inhibits proliferation. This photoluminescent compound shows superior anti-cancer activity compared to its metal-free counterpart.

Area of Science:

  • Chemical Biology
  • Cancer Research
  • Mitochondrial Targeting

Background:

  • Tracking drug distribution in cancer cells is crucial for developing effective cancer therapies.
  • Thiosemicarbazone complexes are investigated for their potential anti-cancer properties.

Purpose of the Study:

  • To design and synthesize a photoluminescent zinc(II)-thiosemicarbazone complex for organelle-specific imaging.
  • To evaluate the anti-cancer proliferation activity of the synthesized complex.

Main Methods:

  • Synthesis of a Zn(II)-thiosemicarbazone complex (Zn(AP44eT)(NO3)2) with a 1:1 metal-to-ligand ratio.
  • Confocal fluorescence imaging to determine cellular localization.
  • Cell cycle analysis (G2 phase) and apoptosis assays in MCF-7 cancer cells.

Main Results:

  • The Zn(AP44eT)(NO3)2 complex exhibited superior fluorescence and anti-tumor activity compared to the metal-free ligand (AP44eT·HCl).
  • Confocal imaging revealed mitochondrial aggregation of the complex.
  • Zn(AP44eT)(NO3)2 effectively shortened the G2 phase and promoted apoptosis in MCF-7 cells.

Conclusions:

  • The synthesized Zn(AP44eT)(NO3)2 complex is a promising photoluminescent agent for mitochondrial imaging in cancer cells.
  • The complex demonstrates significant anti-cancer proliferation effects, likely mediated through mitochondrial pathways and caspase activation.